Advertisement
The Journal of Heart and Lung Transplantation
International Society for Heart and Lung Transplantation.
Original Pre-Clinical Science|Articles in Press

Metabolomic profiling of cardiac allografts after controlled circulatory death

  • Author Footnotes
    1 TH and FL share first authorship.
    Thaïs Hautbergue
    Footnotes
    1 TH and FL share first authorship.
    Affiliations
    Département Médicaments et Technologies pour la Santé (DMTS), MetaboHUB, Paris-Saclay University, CEA, INRAE, Gif-sur-Yvette, France
    Search for articles by this author
  • Author Footnotes
    1 TH and FL share first authorship.
    Florent Laverdure
    Footnotes
    1 TH and FL share first authorship.
    Affiliations
    Department of Anesthesiology and Intensive Care, Hôpital Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Paris-Saclay University, Pulmonary Hypertension National Referral Center, Le Plessis Robinson, France

    Preclinical Research Laboratory, Paris-Saclay University, Hôpital Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Pulmonary Hypertension National Referral Center, Le Plessis Robinson, France
    Search for articles by this author
  • Simon Dang Van
    Affiliations
    Preclinical Research Laboratory, Paris-Saclay University, Hôpital Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Pulmonary Hypertension National Referral Center, Le Plessis Robinson, France
    Search for articles by this author
  • Aurelien Vallee
    Affiliations
    Preclinical Research Laboratory, Paris-Saclay University, Hôpital Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Pulmonary Hypertension National Referral Center, Le Plessis Robinson, France

    Department of Cardiac Surgery, Paris-Saclay University, Hôpital Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Pulmonary Hypertension National Referral Center, Le Plessis Robinson, France
    Search for articles by this author
  • Mateo Sanchis-Borja
    Affiliations
    Preclinical Research Laboratory, Paris-Saclay University, Hôpital Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Pulmonary Hypertension National Referral Center, Le Plessis Robinson, France
    Search for articles by this author
  • Benoît Decante
    Affiliations
    Preclinical Research Laboratory, Paris-Saclay University, Hôpital Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Pulmonary Hypertension National Referral Center, Le Plessis Robinson, France
    Search for articles by this author
  • Maïra Gaillard
    Affiliations
    Preclinical Research Laboratory, Paris-Saclay University, Hôpital Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Pulmonary Hypertension National Referral Center, Le Plessis Robinson, France

    Department of Cardiac Surgery, Paris-Saclay University, Hôpital Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Pulmonary Hypertension National Referral Center, Le Plessis Robinson, France
    Search for articles by this author
  • Christophe Junot
    Affiliations
    Département Médicaments et Technologies pour la Santé (DMTS), MetaboHUB, Paris-Saclay University, CEA, INRAE, Gif-sur-Yvette, France
    Search for articles by this author
  • François Fenaille
    Affiliations
    Département Médicaments et Technologies pour la Santé (DMTS), MetaboHUB, Paris-Saclay University, CEA, INRAE, Gif-sur-Yvette, France
    Search for articles by this author
  • Olaf Mercier
    Affiliations
    Preclinical Research Laboratory, Paris-Saclay University, Hôpital Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Pulmonary Hypertension National Referral Center, Le Plessis Robinson, France

    Department of Thoracic and Vascular Surgery and Heart-Lung Transplantation, Paris-Saclay University, Hôpital Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Pulmonary Hypertension National Referral Center, Le Plessis Robinson, France

    INSERM UMR_S 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies, Paris-Saclay University, Hôpital Marie Lannelongue, Le Plessis-Robinson, France

    Paris-Saclay University School of Medicine, Le Kremlin-Bicêtre, France
    Search for articles by this author
  • Author Footnotes
    2 These authors have contributed equally to this work.
    Benoit Colsch
    Footnotes
    2 These authors have contributed equally to this work.
    Affiliations
    Département Médicaments et Technologies pour la Santé (DMTS), MetaboHUB, Paris-Saclay University, CEA, INRAE, Gif-sur-Yvette, France
    Search for articles by this author
  • Author Footnotes
    2 These authors have contributed equally to this work.
    Julien Guihaire
    Correspondence
    Reprint requests: Julien Guihaire, MD, PhD, Department of Cardiac Surgery, Hôpital Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, 133 Avenue de la Resistance, Le Plessis Robinson, 92350 France. Telephone: +33 140-94-8607; Fax: +33 14-094-2443
    Footnotes
    2 These authors have contributed equally to this work.
    Affiliations
    Preclinical Research Laboratory, Paris-Saclay University, Hôpital Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Pulmonary Hypertension National Referral Center, Le Plessis Robinson, France

    Department of Cardiac Surgery, Paris-Saclay University, Hôpital Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Pulmonary Hypertension National Referral Center, Le Plessis Robinson, France

    Department of Thoracic and Vascular Surgery and Heart-Lung Transplantation, Paris-Saclay University, Hôpital Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Pulmonary Hypertension National Referral Center, Le Plessis Robinson, France
    Search for articles by this author
  • Author Footnotes
    1 TH and FL share first authorship.
    2 These authors have contributed equally to this work.
Published:February 22, 2023DOI:https://doi.org/10.1016/j.healun.2023.02.1492

      Background

      Assessment of myocardial viability during ex situ heart perfusion (ESHP) is based on the measurement of lactate concentrations. As this provides with limited information, we sought to investigate the metabolic signature associated with donation after circulatory death (DCD) and the impact of ESHP on the myocardial metabolome.

      Methods

      Porcine hearts were retrieved either after warm ischemia (DCD group, N = 6); after brain-stem death (BSD group, N = 6); or without DCD nor BSD (Control group, N = 6). Hearts were perfused using normothermic oxygenated blood for 240 minutes. Plasma and myocardial samples were collected respectively every 30 and 60 minutes, and analyzed by an untargeted metabolomic approach using liquid chromatography coupled to high-resolution mass spectrometry.

      Results

      Median duration of warm ischemia was 23 minutes [19-29] in DCD animals. Lactate level within myocardial biopsies was not significantly different between groups at T0 (p = 0.281), and remained stable over the 4-hour period of ESHP. More than 300 metabolites were detected in plasma and heart biopsy samples. Compared to BSD animals, metabolomics changes involving energy and nucleotide metabolisms were observed in plasma samples of DCD animals before initiation of ESHP, whereas 2 metabolites (inosine monophosphate and methylbutyrate) exhibited concentration changes in biopsy samples. Normalization of DCD metabolic profile was remarkable after 4 hours of ESHP.

      Conclusion

      A specific metabolic profile was observed in DCD hearts, mainly characterized by an increased nucleotide catabolism. DCD and BSD metabolomes proved normalized during ESHP. Complementary investigations are needed to correlate these findings to cardiac performances.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Heart and Lung Transplantation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Khush KK
        • Potena L
        • Cherikh WS
        • et al.
        The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 37th adult heart transplantation report-2020; focus on deceased donor characteristics.
        J Heart Lung Transplant. 2020; 39: 1003-1015
        • Chew HC
        • Iyer A
        • Connellan M
        • et al.
        Outcomes of donation after circulatory death heart transplantation in Australia.
        J Am Coll Cardiol. 2019; 73: 1447-1459
        • Messer S
        • Cernic S
        • Page A
        • et al.
        A 5-year single-center early experience of heart transplantation from donation after circulatory-determined death donors.
        J Heart Lung Transplant. 2020; 39: 1463-1475
        • Dhital KK
        • Chew HC
        • Macdonald PS
        Donation after circulatory death heart transplantation.
        Curr Opin Organ Transplant. 2017; 22: 189-197
        • Dhital KK
        • Iyer A
        • Connellan M
        • et al.
        Adult heart transplantation with distant procurement and ex-vivo preservation of donor hearts after circulatory death: a case series.
        Lancet (London, England). 2015; 385: 2585-2591
        • Hamed A
        • Tsui S
        • Huber J
        • Lin R
        • Poggio EC
        • Ardehali A
        19: Serum lactate is a highly sensitive and specific predictor of post cardiac transplant outcomes using the organ care system.
        J Heart Lung Transplant. 2009; 28: S71
        • Hautbergue T
        • Antigny F
        • Boët A
        • et al.
        Right ventricle remodeling metabolic signature in experimental pulmonary hypertension models of chronic hypoxia and monocrotaline exposure.
        Cells. 2021; 10: 1559
        • Junot C
        • Fenaille F
        • Colsch B
        • Becher F
        High resolution mass spectrometry based techniques at the crossroads of metabolic pathways.
        Mass Spectrom Rev. 2014; 33: 471-500
        • Kvietkauskas M
        • Zitkute V
        • Leber B
        • Strupas K
        • Stiegler P
        • Schemmer P
        The role of metabolomics in current concepts of organ preservation.
        Int J Mole Sci. 2020; 21: 6607
        • Guy AJ
        • Nath J
        • Cobbold M
        • et al.
        Metabolomic analysis of perfusate during hypothermic machine perfusion of human cadaveric kidneys.
        Transplantation. 2015; 99: 754-759
        • Raigani S
        • Karimian N
        • Huang V
        • et al.
        Metabolic and lipidomic profiling of steatotic human livers during ex situ normothermic machine perfusion guides resuscitation strategies.
        PloS one. 2020; 15e0228011
        • Shin J
        • Hsin MK
        • Baciu C
        • et al.
        Use of metabolomics to identify strategies to improve and prolong ex vivo lung perfusion for lung transplants.
        J Heart Lung Transplant. 2021; 40: 525-535
        • Kilkenny C
        • Browne W
        • Cuthill IC
        • Emerson M
        • Altman DG
        Animal research: reporting in vivo experiments: the ARRIVE guidelines.
        Br J Pharmacol. 2010; 160: 1577-1579
        • Purins K
        • Sedigh A
        • Molnar C
        • et al.
        Standardized experimental brain death model for studies of intracranial dynamics, organ preservation, and organ transplantation in the pig.
        Crit Care Med. 2011; 39: 512-517
        • Boudah S
        • Olivier MF
        • Aros-Calt S
        • et al.
        Annotation of the human serum metabolome by coupling three liquid chromatography methods to high-resolution mass spectrometry.
        J Chromatography B, Analyt Technol Biomed Life Sci. 2014; 966: 34-47
        • Giacomoni F
        • Le Corguillé G
        • Monsoor M
        • et al.
        Workflow4Metabolomics: a collaborative research infrastructure for computational metabolomics.
        Bioinformatics (Oxford, England). 2015; 31: 1493-1495
      1. LW Sumner, A Amberg, D Barrett, et al. Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics 2007;3:211-221.

        • Benjamini Y
        • Hochberg Y
        Controlling the false discovery rate: a practical and powerful approach to multiple testing.
        J Royal Stats Soc: Series B (Methodological). 1995; 57: 289-300
        • Bodi V
        • Marrachelli VG
        • Husser O
        • Chorro FJ
        • Viña JR
        • Monleon D
        Metabolomics in the diagnosis of acute myocardial ischemia.
        J Cardiovasc Transl Res. 2013; 6: 808-815
        • Cheng S
        • Shah SH
        • Corwin EJ
        • et al.
        Potential impact and study considerations of metabolomics in cardiovascular health and disease: a scientific statement From the American Heart Association.
        Circ Cardiovasc Genet. 2017; 10e000032
        • Griffin JL
        • Atherton H
        • Shockcor J
        • Atzori L
        Metabolomics as a tool for cardiac research.
        Nat Rev Cardiol. 2011; 8: 630-643
        • McGarrah RW
        • Crown SB
        • Zhang GF
        • Shah SH
        • Newgard CB
        Cardiovascular Metabolomics.
        Circ Res. 2018; 122: 1238-1258
        • Ardehali A
        • Esmailian F
        • Deng M
        • et al.
        Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial.
        Lancet (London, England). 2015; 385: 2577-2584
        • Guariento A
        • Doulamis IP
        • Duignan T
        • et al.
        Mitochondrial transplantation for myocardial protection in ex-situ‒perfused hearts donated after circulatory death.
        J Heart Lung Transplant. 2020; 39: 1279-1288
        • Messer S
        • Large S
        Resuscitating heart transplantation: the donation after circulatory determined death donor.
        Eur J Cardio-Thorac Surg. 2016; 49: 1-4
        • Quader M
        • Toldo S
        • Chen Q
        • Hundley G
        • Kasirajan V
        Heart transplantation from donation after circulatory death donors: present and future.
        J Card Surg. 2020; 35: 875-885
        • White CW
        • Hasanally D
        • Mundt P
        • et al.
        A whole blood-based perfusate provides superior preservation of myocardial function during ex vivo heart perfusion.
        J Heart Lung Transplant. 2015; 34: 113-121
        • Bartels GL
        • Remme WJ
        • Scholte HR
        Acute myocardial ischaemia induces cardiac carnitine release in man.
        Eur Heart J. 1997; 18: 84-90
        • Martin JL
        • Costa ASH
        • Gruszczyk AV
        • et al.
        Succinate accumulation drives ischaemia-reperfusion injury during organ transplantation.
        Nat Metab. 2019; 1: 966-974
        • Wang ZY
        • Liu YY
        • Liu GH
        • Lu HB
        • Mao CY
        l-Carnitine and heart disease.
        Life Sci. 2018; 194: 88-97
        • Lv Y
        • Liu X
        • Yan S
        • et al.
        Metabolomic study of myocardial ischemia and intervention effects of Compound Danshen Tablets in rats using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
        J Pharmaceut Biomed Anal. 2010; 52: 129-135
        • Bai H
        • Sun K
        • Wu JH
        • et al.
        Proteomic and metabolomic characterization of cardiac tissue in acute myocardial ischemia injury rats.
        PloS One. 2020; 15e0231797
        • Chouchani ET
        • Pell VR
        • Gaude E
        • et al.
        Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS.
        Nature. 2014; 515: 431-435
        • Harmsen E
        • de Jong JW
        • Serruys PW
        Hypoxanthine production by ischemic heart demonstrated by high pressure liquid chromatography of blood purine nucleosides and oxypurines.
        Clin Chim Acta. 1981; 115: 73-84
        • Farthing DE
        • Farthing CA
        • Xi L
        Inosine and hypoxanthine as novel biomarkers for cardiac ischemia: from bench to point-of-care.
        Exp Biol Med (Maywood, NJ). 2015; 240: 821-831
        • Ali AA
        • White P
        • Xiang B
        • et al.
        Hearts from DCD donors display acceptable biventricular function after heart transplantation in pigs.
        Am J Transplant. 2011; 11: 1621-1632
        • Messer S
        • Page A
        • Axell R
        • et al.
        Outcome after heart transplantation from donation after circulatory-determined death donors.
        J Heart Lung Transplant. 2017; 36: 1311-1318
        • Molina-Arcas M
        • Casado FJ
        • Pastor-Anglada M
        Nucleoside transporter proteins.
        Curr Vasc Pharmacol. 2009; 7: 426-434